2023 Life Sciences Digital Pathology Adoption Survey Report
- DHV-NET
- Jun 14, 2023
- 1 min read
Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®.
